RxDoctor Payments Data

Joslyn Gober

Pediatric Rehabilitation Medicine · Miami, FLNPI 1083024293

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 64 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. AbbVie accounts for 65.9% of it on its own, with 11 other manufacturers making up the rest.

$1,747in general payments, 2019–2025

Across 64 payments — averaging $27.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Genentech USA, Inc.$158
  • Piramal Critical Care$120
  • Biogen$61
  • Catalyst Pharmaceuticals, Inc.$54
  • Saol Therapeutics Inc.$48
  • plus $155 from 6 others

What the payments were for

  • Food & beverage$1,747100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)44$1,152
Genentech USA, Inc.6$158
Piramal Critical Care2$120
Biogen3$61
Catalyst Pharmaceuticals, Inc.2$54
Saol Therapeutics Inc.1$48
Jazz Pharmaceuticals Inc.1$38
Pfizer1$36
Novartis Gene Therapies, Inc. (fka Avexis, Inc.)1$28
NS Pharma, Inc.1$22
ITF Therapeutics LLC1$19
Metacel Pharmaceuticals LLC1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few pediatric rehabilitation medicine providers in Floridato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$6,726
Medicare patients
45
Services billed
55

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Baclofen11$221

Paid to pharmacies, not to this prescriber.

Other pediatric rehabilitation medicine in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →